0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Polylactic Acid for Medical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Published Date: 2026-06-19
|
Report Code: QYRE-Auto-14T14739
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Polylactic Acid for Medical Market Research Report 2023
BUY CHAPTERS

Polylactic Acid for Medical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Code: QYRE-Auto-14T14739
Report
2026-06-19
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Polylactic Acid for Medical- Market Size

The global market for Polylactic Acid for Medical was estimated to be worth US$ 135 million in 2025 and is projected to reach US$ 206 million, growing at a CAGR of 6.3% from 2026 to 2032.

Polylactic Acid for Medical- Market

Polylactic Acid for Medical- Market

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Polylactic Acid for Medical cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Polylactic acid (PLA) is a biodegradable and biocompatible polymer that has gained significant attention in the medical field. It is derived from renewable resources such as cornstarch or sugarcane, making it an attractive alternative to petroleum-based plastics.
The North American market for Polylactic Acid for Medical was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Polylactic Acid for Medical was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Polylactic Acid for Medical was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Polylactic Acid for Medical market include NatureWorks, Corbion, Futerro, Teijin, Toray, Musashino, Sulzer, Galactic, Zhejiang Hisun Biomaterials, Shanghai Tong-jie-liang Biomaterials, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Polylactic Acid for Medical, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Polylactic Acid for Medical market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Polylactic Acid for Medical.
Market Segmentation

Scope of Polylactic Acid for Medical- Market Report

Report Metric Details
Report Name Polylactic Acid for Medical- Market
CAGR 6.3%
Segment by Type
  • PLLA
  • PDLA
  • PDLLA
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company NatureWorks, Corbion, Futerro, Teijin, Toray, Musashino, Sulzer, Galactic, Zhejiang Hisun Biomaterials, Shanghai Tong-jie-liang Biomaterials, Shenzhen Esun Industrial, BBCA Biochemical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
  • Chapter 2: Provides a detailed analysis of the Polylactic Acid for Medical manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
  • Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Presents Polylactic Acid for Medical sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
  • Chapter 6: Presents Polylactic Acid for Medical sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
  • Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
  • Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Polylactic Acid for Medical- Market report?

Ans: The main players in the Polylactic Acid for Medical- Market are NatureWorks, Corbion, Futerro, Teijin, Toray, Musashino, Sulzer, Galactic, Zhejiang Hisun Biomaterials, Shanghai Tong-jie-liang Biomaterials, Shenzhen Esun Industrial, BBCA Biochemical

What are the Application segmentation covered in the Polylactic Acid for Medical- Market report?

Ans: The Applications covered in the Polylactic Acid for Medical- Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Polylactic Acid for Medical- Market report?

Ans: The Types covered in the Polylactic Acid for Medical- Market report are PLLA, PDLA, PDLLA

1 Market Overview
1.1 Polylactic Acid for Medical Product Introduction
1.2 Global Polylactic Acid for Medical Market Size Forecast
1.2.1 Global Polylactic Acid for Medical Sales Value (2021–2032)
1.2.2 Global Polylactic Acid for Medical Sales Volume (2021–2032)
1.2.3 Global Polylactic Acid for Medical Sales Price (2021–2032)
1.3 Polylactic Acid for Medical Market Trends & Drivers
1.3.1 Polylactic Acid for Medical Industry Trends
1.3.2 Polylactic Acid for Medical Market Drivers & Opportunities
1.3.3 Polylactic Acid for Medical Market Challenges
1.3.4 Polylactic Acid for Medical Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Polylactic Acid for Medical Players Revenue Ranking (2025)
2.2 Global Polylactic Acid for Medical Revenue by Company (2021–2026)
2.3 Global Polylactic Acid for Medical Sales Volume Ranking of Players (2025)
2.4 Global Polylactic Acid for Medical Sales Volume by Company (2021–2026)
2.5 Global Polylactic Acid for Medical Average Price by Company (2021–2026)
2.6 Key Manufacturers Polylactic Acid for Medical Manufacturing Base and Headquarters
2.7 Key Manufacturers Polylactic Acid for Medical Product Offerings
2.8 Key Manufacturers Start of Mass Production of Polylactic Acid for Medical
2.9 Polylactic Acid for Medical Market Competitive Analysis
2.9.1 Polylactic Acid for Medical Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Polylactic Acid for Medical Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Polylactic Acid for Medical revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Polylactic Acid for Medical Market Classification
3.1 Introduction by Type
3.1.1 PLLA
3.1.2 PDLA
3.1.3 PDLLA
3.1.4 Global Polylactic Acid for Medical Sales Value by Type
3.1.4.1 Global Polylactic Acid for Medical Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Polylactic Acid for Medical Sales Value, by Type (2021–2032)
3.1.4.3 Global Polylactic Acid for Medical Sales Value, by Type (%), 2021–2032
3.1.5 Global Polylactic Acid for Medical Sales Volume by Type
3.1.5.1 Global Polylactic Acid for Medical Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Polylactic Acid for Medical Sales Volume, by Type (2021–2032)
3.1.5.3 Global Polylactic Acid for Medical Sales Volume, by Type (%), 2021–2032
3.1.6 Global Polylactic Acid for Medical Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Polylactic Acid for Medical Sales Value by Application
4.2.1 Global Polylactic Acid for Medical Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Polylactic Acid for Medical Sales Value, by Application (2021–2032)
4.2.3 Global Polylactic Acid for Medical Sales Value, by Application (%), 2021–2032
4.3 Global Polylactic Acid for Medical Sales Volume by Application
4.3.1 Global Polylactic Acid for Medical Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Polylactic Acid for Medical Sales Volume, by Application (2021–2032)
4.3.3 Global Polylactic Acid for Medical Sales Volume, by Application (%), 2021–2032
4.4 Global Polylactic Acid for Medical Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Polylactic Acid for Medical Sales Value by Region
5.1.1 Global Polylactic Acid for Medical Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Polylactic Acid for Medical Sales Value by Region (2021–2026)
5.1.3 Global Polylactic Acid for Medical Sales Value by Region (2027–2032)
5.1.4 Global Polylactic Acid for Medical Sales Value by Region (%), 2021–2032
5.2 Global Polylactic Acid for Medical Sales Volume by Region
5.2.1 Global Polylactic Acid for Medical Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Polylactic Acid for Medical Sales Volume by Region (2021–2026)
5.2.3 Global Polylactic Acid for Medical Sales Volume by Region (2027–2032)
5.2.4 Global Polylactic Acid for Medical Sales Volume by Region (%), 2021–2032
5.3 Global Polylactic Acid for Medical Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Polylactic Acid for Medical Sales Value, 2021–2032
5.4.2 North America Polylactic Acid for Medical Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Polylactic Acid for Medical Sales Value, 2021–2032
5.5.2 Europe Polylactic Acid for Medical Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Polylactic Acid for Medical Sales Value, 2021–2032
5.6.2 Asia Pacific Polylactic Acid for Medical Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Polylactic Acid for Medical Sales Value, 2021–2032
5.7.2 South America Polylactic Acid for Medical Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Polylactic Acid for Medical Sales Value, 2021–2032
5.8.2 Middle East & Africa Polylactic Acid for Medical Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Polylactic Acid for Medical Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Polylactic Acid for Medical Sales Value and Sales Volume
6.2.1 Key Countries/Regions Polylactic Acid for Medical Sales Value, 2021–2032
6.2.2 Key Countries/Regions Polylactic Acid for Medical Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Polylactic Acid for Medical Sales Value, 2021–2032
6.3.2 United States Polylactic Acid for Medical Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Polylactic Acid for Medical Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Polylactic Acid for Medical Sales Value, 2021–2032
6.4.2 Europe Polylactic Acid for Medical Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Polylactic Acid for Medical Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Polylactic Acid for Medical Sales Value, 2021–2032
6.5.2 China Polylactic Acid for Medical Sales Value by Type (%), 2025 vs 2032
6.5.3 China Polylactic Acid for Medical Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Polylactic Acid for Medical Sales Value, 2021–2032
6.6.2 Japan Polylactic Acid for Medical Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Polylactic Acid for Medical Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Polylactic Acid for Medical Sales Value, 2021–2032
6.7.2 South Korea Polylactic Acid for Medical Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Polylactic Acid for Medical Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Polylactic Acid for Medical Sales Value, 2021–2032
6.8.2 Southeast Asia Polylactic Acid for Medical Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Polylactic Acid for Medical Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Polylactic Acid for Medical Sales Value, 2021–2032
6.9.2 India Polylactic Acid for Medical Sales Value by Type (%), 2025 vs 2032
6.9.3 India Polylactic Acid for Medical Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 NatureWorks
7.1.1 NatureWorks Company Information
7.1.2 NatureWorks Introduction and Business Overview
7.1.3 NatureWorks Polylactic Acid for Medical Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 NatureWorks Polylactic Acid for Medical Product Offerings
7.1.5 NatureWorks Recent Developments
7.2 Corbion
7.2.1 Corbion Company Information
7.2.2 Corbion Introduction and Business Overview
7.2.3 Corbion Polylactic Acid for Medical Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Corbion Polylactic Acid for Medical Product Offerings
7.2.5 Corbion Recent Developments
7.3 Futerro
7.3.1 Futerro Company Information
7.3.2 Futerro Introduction and Business Overview
7.3.3 Futerro Polylactic Acid for Medical Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Futerro Polylactic Acid for Medical Product Offerings
7.3.5 Futerro Recent Developments
7.4 Teijin
7.4.1 Teijin Company Information
7.4.2 Teijin Introduction and Business Overview
7.4.3 Teijin Polylactic Acid for Medical Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Teijin Polylactic Acid for Medical Product Offerings
7.4.5 Teijin Recent Developments
7.5 Toray
7.5.1 Toray Company Information
7.5.2 Toray Introduction and Business Overview
7.5.3 Toray Polylactic Acid for Medical Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Toray Polylactic Acid for Medical Product Offerings
7.5.5 Toray Recent Developments
7.6 Musashino
7.6.1 Musashino Company Information
7.6.2 Musashino Introduction and Business Overview
7.6.3 Musashino Polylactic Acid for Medical Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Musashino Polylactic Acid for Medical Product Offerings
7.6.5 Musashino Recent Developments
7.7 Sulzer
7.7.1 Sulzer Company Information
7.7.2 Sulzer Introduction and Business Overview
7.7.3 Sulzer Polylactic Acid for Medical Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Sulzer Polylactic Acid for Medical Product Offerings
7.7.5 Sulzer Recent Developments
7.8 Galactic
7.8.1 Galactic Company Information
7.8.2 Galactic Introduction and Business Overview
7.8.3 Galactic Polylactic Acid for Medical Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Galactic Polylactic Acid for Medical Product Offerings
7.8.5 Galactic Recent Developments
7.9 Zhejiang Hisun Biomaterials
7.9.1 Zhejiang Hisun Biomaterials Company Information
7.9.2 Zhejiang Hisun Biomaterials Introduction and Business Overview
7.9.3 Zhejiang Hisun Biomaterials Polylactic Acid for Medical Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Zhejiang Hisun Biomaterials Polylactic Acid for Medical Product Offerings
7.9.5 Zhejiang Hisun Biomaterials Recent Developments
7.10 Shanghai Tong-jie-liang Biomaterials
7.10.1 Shanghai Tong-jie-liang Biomaterials Company Information
7.10.2 Shanghai Tong-jie-liang Biomaterials Introduction and Business Overview
7.10.3 Shanghai Tong-jie-liang Biomaterials Polylactic Acid for Medical Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Shanghai Tong-jie-liang Biomaterials Polylactic Acid for Medical Product Offerings
7.10.5 Shanghai Tong-jie-liang Biomaterials Recent Developments
7.11 Shenzhen Esun Industrial
7.11.1 Shenzhen Esun Industrial Company Information
7.11.2 Shenzhen Esun Industrial Introduction and Business Overview
7.11.3 Shenzhen Esun Industrial Polylactic Acid for Medical Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Shenzhen Esun Industrial Polylactic Acid for Medical Product Offerings
7.11.5 Shenzhen Esun Industrial Recent Developments
7.12 BBCA Biochemical
7.12.1 BBCA Biochemical Company Information
7.12.2 BBCA Biochemical Introduction and Business Overview
7.12.3 BBCA Biochemical Polylactic Acid for Medical Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 BBCA Biochemical Polylactic Acid for Medical Product Offerings
7.12.5 BBCA Biochemical Recent Developments
8 Industry Chain Analysis
8.1 Polylactic Acid for Medical Industrial Chain
8.2 Polylactic Acid for Medical Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Polylactic Acid for Medical Sales Model
8.5.2 Sales Channels
8.5.3 Polylactic Acid for Medical Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Polylactic Acid for Medical Market Trends
 Table 2. Polylactic Acid for Medical Market Drivers & Opportunities
 Table 3. Polylactic Acid for Medical Market Challenges
 Table 4. Polylactic Acid for Medical Market Restraints
 Table 5. Global Polylactic Acid for Medical Revenue by Company (US$ Million), 2021–2026
 Table 6. Global Polylactic Acid for Medical Revenue Market Share by Company (2021–2026)
 Table 7. Global Polylactic Acid for Medical Sales Volume by Company (Tons), 2021–2026
 Table 8. Global Polylactic Acid for Medical Sales Volume Market Share by Company (2021–2026)
 Table 9. Global Market Polylactic Acid for Medical Price by Company (US$/Ton), 2021–2026
 Table 10. Key Manufacturers Polylactic Acid for Medical Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Polylactic Acid for Medical Product Type
 Table 12. Key Manufacturers Start of Mass Production of Polylactic Acid for Medical
 Table 13. Global Polylactic Acid for Medical Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Polylactic Acid for Medical revenue, 2025
 Table 15. Mergers & Acquisitions and Expansion Plans
 Table 16. Global Polylactic Acid for Medical Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
 Table 17. Global Polylactic Acid for Medical Sales Value by Type (US$ Million), 2021–2026
 Table 18. Global Polylactic Acid for Medical Sales Value by Type (US$ Million), 2027–2032
 Table 19. Global Polylactic Acid for Medical Sales Market Share in Value by Type (2021–2026)
 Table 20. Global Polylactic Acid for Medical Sales Market Share in Value by Type (2027–2032)
 Table 21. Global Polylactic Acid for Medical Sales Volume by Type: 2021 vs 2025 vs 2032 (Tons)
 Table 22. Global Polylactic Acid for Medical Sales Volume by Type (Tons), 2021–2026
 Table 23. Global Polylactic Acid for Medical Sales Volume by Type (Tons), 2027–2032
 Table 24. Global Polylactic Acid for Medical Sales Market Share in Volume by Type (2021–2026)
 Table 25. Global Polylactic Acid for Medical Sales Market Share in Volume by Type (2027–2032)
 Table 26. Global Polylactic Acid for Medical Price by Type (US$/Ton), 2021–2026
 Table 27. Global Polylactic Acid for Medical Price by Type (US$/Ton), 2027–2032
 Table 28. Global Polylactic Acid for Medical Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
 Table 29. Global Polylactic Acid for Medical Sales Value by Application (US$ Million), 2021–2026
 Table 30. Global Polylactic Acid for Medical Sales Value by Application (US$ Million), 2027–2032
 Table 31. Global Polylactic Acid for Medical Sales Market Share in Value by Application (2021–2026)
 Table 32. Global Polylactic Acid for Medical Sales Market Share in Value by Application (2027–2032)
 Table 33. Global Polylactic Acid for Medical Sales Volume by Application: 2021 vs 2025 vs 2032 (Tons)
 Table 34. Global Polylactic Acid for Medical Sales Volume by Application (Tons), 2021–2026
 Table 35. Global Polylactic Acid for Medical Sales Volume by Application (Tons), 2027–2032
 Table 36. Global Polylactic Acid for Medical Sales Market Share in Volume by Application (2021–2026)
 Table 37. Global Polylactic Acid for Medical Sales Market Share in Volume by Application (2027–2032)
 Table 38. Global Polylactic Acid for Medical Price by Application (US$/Ton), 2021–2026
 Table 39. Global Polylactic Acid for Medical Price by Application (US$/Ton), 2027–2032
 Table 40. Global Polylactic Acid for Medical Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
 Table 41. Global Polylactic Acid for Medical Sales Value by Region (US$ Million), 2021–2026
 Table 42. Global Polylactic Acid for Medical Sales Value by Region (US$ Million), 2027–2032
 Table 43. Global Polylactic Acid for Medical Sales Value by Region (%), 2021–2026
 Table 44. Global Polylactic Acid for Medical Sales Value by Region (%), 2027–2032
 Table 45. Global Polylactic Acid for Medical Sales Volume by Region (Tons): 2021 vs 2025 vs 2032
 Table 46. Global Polylactic Acid for Medical Sales Volume by Region (Tons), 2021–2026
 Table 47. Global Polylactic Acid for Medical Sales Volume by Region (Tons), 2027–2032
 Table 48. Global Polylactic Acid for Medical Sales Volume by Region (%), 2021–2026
 Table 49. Global Polylactic Acid for Medical Sales Volume by Region (%), 2027–2032
 Table 50. Global Polylactic Acid for Medical Average Price by Region (US$/Ton), 2021–2026
 Table 51. Global Polylactic Acid for Medical Average Price by Region (US$/Ton), 2027–2032
 Table 52. Key Countries/Regions Polylactic Acid for Medical Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
 Table 53. Key Countries/Regions Polylactic Acid for Medical Sales Value, (US$ Million), 2021–2026
 Table 54. Key Countries/Regions Polylactic Acid for Medical Sales Value, (US$ Million), 2027–2032
 Table 55. Key Countries/Regions Polylactic Acid for Medical Sales Volume, (Tons), 2021–2026
 Table 56. Key Countries/Regions Polylactic Acid for Medical Sales Volume, (Tons), 2027–2032
 Table 57. NatureWorks Company Information
 Table 58. NatureWorks Introduction and Business Overview
 Table 59. NatureWorks Polylactic Acid for Medical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 60. NatureWorks Polylactic Acid for Medical Product Offerings
 Table 61. NatureWorks Recent Developments
 Table 62. Corbion Company Information
 Table 63. Corbion Introduction and Business Overview
 Table 64. Corbion Polylactic Acid for Medical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 65. Corbion Polylactic Acid for Medical Product Offerings
 Table 66. Corbion Recent Developments
 Table 67. Futerro Company Information
 Table 68. Futerro Introduction and Business Overview
 Table 69. Futerro Polylactic Acid for Medical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 70. Futerro Polylactic Acid for Medical Product Offerings
 Table 71. Futerro Recent Developments
 Table 72. Teijin Company Information
 Table 73. Teijin Introduction and Business Overview
 Table 74. Teijin Polylactic Acid for Medical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 75. Teijin Polylactic Acid for Medical Product Offerings
 Table 76. Teijin Recent Developments
 Table 77. Toray Company Information
 Table 78. Toray Introduction and Business Overview
 Table 79. Toray Polylactic Acid for Medical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 80. Toray Polylactic Acid for Medical Product Offerings
 Table 81. Toray Recent Developments
 Table 82. Musashino Company Information
 Table 83. Musashino Introduction and Business Overview
 Table 84. Musashino Polylactic Acid for Medical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 85. Musashino Polylactic Acid for Medical Product Offerings
 Table 86. Musashino Recent Developments
 Table 87. Sulzer Company Information
 Table 88. Sulzer Introduction and Business Overview
 Table 89. Sulzer Polylactic Acid for Medical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 90. Sulzer Polylactic Acid for Medical Product Offerings
 Table 91. Sulzer Recent Developments
 Table 92. Galactic Company Information
 Table 93. Galactic Introduction and Business Overview
 Table 94. Galactic Polylactic Acid for Medical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 95. Galactic Polylactic Acid for Medical Product Offerings
 Table 96. Galactic Recent Developments
 Table 97. Zhejiang Hisun Biomaterials Company Information
 Table 98. Zhejiang Hisun Biomaterials Introduction and Business Overview
 Table 99. Zhejiang Hisun Biomaterials Polylactic Acid for Medical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 100. Zhejiang Hisun Biomaterials Polylactic Acid for Medical Product Offerings
 Table 101. Zhejiang Hisun Biomaterials Recent Developments
 Table 102. Shanghai Tong-jie-liang Biomaterials Company Information
 Table 103. Shanghai Tong-jie-liang Biomaterials Introduction and Business Overview
 Table 104. Shanghai Tong-jie-liang Biomaterials Polylactic Acid for Medical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 105. Shanghai Tong-jie-liang Biomaterials Polylactic Acid for Medical Product Offerings
 Table 106. Shanghai Tong-jie-liang Biomaterials Recent Developments
 Table 107. Shenzhen Esun Industrial Company Information
 Table 108. Shenzhen Esun Industrial Introduction and Business Overview
 Table 109. Shenzhen Esun Industrial Polylactic Acid for Medical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 110. Shenzhen Esun Industrial Polylactic Acid for Medical Product Offerings
 Table 111. Shenzhen Esun Industrial Recent Developments
 Table 112. BBCA Biochemical Company Information
 Table 113. BBCA Biochemical Introduction and Business Overview
 Table 114. BBCA Biochemical Polylactic Acid for Medical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 115. BBCA Biochemical Polylactic Acid for Medical Product Offerings
 Table 116. BBCA Biochemical Recent Developments
 Table 117. Key Raw Materials Lists
 Table 118. Key Suppliers of Raw Materials Lists
 Table 119. Polylactic Acid for Medical Downstream Customers
 Table 120. Polylactic Acid for Medical Distributors List
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources


List of Figures
 Figure 1. Polylactic Acid for Medical Product Picture
 Figure 2. Global Polylactic Acid for Medical Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. Global Polylactic Acid for Medical Sales Value (US$ Million), 2021–2032
 Figure 4. Global Polylactic Acid for Medical Sales Volume (Tons), 2021–2032
 Figure 5. Global Polylactic Acid for Medical Sales Price (US$/Ton), 2021–2032
 Figure 6. Polylactic Acid for Medical Report Years Considered
 Figure 7. Global Polylactic Acid for Medical Players Revenue Ranking (US$ Million), 2025
 Figure 8. Global Polylactic Acid for Medical Sales Volume Ranking of Players (Tons), 2025
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Polylactic Acid for Medical Revenue in 2025
 Figure 10. Polylactic Acid for Medical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 11. PLLA Picture
 Figure 12. PDLA Picture
 Figure 13. PDLLA Picture
 Figure 14. Global Polylactic Acid for Medical Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Polylactic Acid for Medical Sales Value Market Share by Type, 2025 & 2032
 Figure 16. Global Polylactic Acid for Medical Sales Volume by Type (Tons), 2021 vs 2025 vs 2032
 Figure 17. Global Polylactic Acid for Medical Sales Volume Market Share by Type, 2025 & 2032
 Figure 18. Global Polylactic Acid for Medical Price by Type (US$/Ton), 2021–2032
 Figure 19. Product Picture of Hospital
 Figure 20. Product Picture of Clinic
 Figure 21. Product Picture of Other
 Figure 22. Global Polylactic Acid for Medical Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
 Figure 23. Global Polylactic Acid for Medical Sales Value Market Share by Application, 2025 & 2032
 Figure 24. Global Polylactic Acid for Medical Sales Volume by Application (Tons), 2021 vs 2025 vs 2032
 Figure 25. Global Polylactic Acid for Medical Sales Volume Market Share by Application, 2025 & 2032
 Figure 26. Global Polylactic Acid for Medical Price by Application (US$/Ton), 2021–2032
 Figure 27. North America Polylactic Acid for Medical Sales Value (US$ Million), 2021–2032
 Figure 28. North America Polylactic Acid for Medical Sales Value by Country (%), 2025 vs 2032
 Figure 29. Europe Polylactic Acid for Medical Sales Value (US$ Million), 2021–2032
 Figure 30. Europe Polylactic Acid for Medical Sales Value by Country (%), 2025 vs 2032
 Figure 31. Asia Pacific Polylactic Acid for Medical Sales Value (US$ Million), 2021–2032
 Figure 32. Asia Pacific Polylactic Acid for Medical Sales Value by Region (%), 2025 vs 2032
 Figure 33. South America Polylactic Acid for Medical Sales Value (US$ Million), 2021–2032
 Figure 34. South America Polylactic Acid for Medical Sales Value by Country (%), 2025 vs 2032
 Figure 35. Middle East & Africa Polylactic Acid for Medical Sales Value (US$ Million), 2021–2032
 Figure 36. Middle East & Africa Polylactic Acid for Medical Sales Value by Country (%), 2025 vs 2032
 Figure 37. Key Countries/Regions Polylactic Acid for Medical Sales Value (%), 2021–2032
 Figure 38. Key Countries/Regions Polylactic Acid for Medical Sales Volume (%), 2021–2032
 Figure 39. United States Polylactic Acid for Medical Sales Value (US$ Million), 2021–2032
 Figure 40. United States Polylactic Acid for Medical Sales Value by Type (%), 2025 vs 2032
 Figure 41. United States Polylactic Acid for Medical Sales Value by Application (%), 2025 vs 2032
 Figure 42. Europe Polylactic Acid for Medical Sales Value (US$ Million), 2021–2032
 Figure 43. Europe Polylactic Acid for Medical Sales Value by Type (%), 2025 vs 2032
 Figure 44. Europe Polylactic Acid for Medical Sales Value by Application (%), 2025 vs 2032
 Figure 45. China Polylactic Acid for Medical Sales Value (US$ Million), 2021–2032
 Figure 46. China Polylactic Acid for Medical Sales Value by Type (%), 2025 vs 2032
 Figure 47. China Polylactic Acid for Medical Sales Value by Application (%), 2025 vs 2032
 Figure 48. Japan Polylactic Acid for Medical Sales Value (US$ Million), 2021–2032
 Figure 49. Japan Polylactic Acid for Medical Sales Value by Type (%), 2025 vs 2032
 Figure 50. Japan Polylactic Acid for Medical Sales Value by Application (%), 2025 vs 2032
 Figure 51. South Korea Polylactic Acid for Medical Sales Value (US$ Million), 2021–2032
 Figure 52. South Korea Polylactic Acid for Medical Sales Value by Type (%), 2025 vs 2032
 Figure 53. South Korea Polylactic Acid for Medical Sales Value by Application (%), 2025 vs 2032
 Figure 54. Southeast Asia Polylactic Acid for Medical Sales Value (US$ Million), 2021–2032
 Figure 55. Southeast Asia Polylactic Acid for Medical Sales Value by Type (%), 2025 vs 2032
 Figure 56. Southeast Asia Polylactic Acid for Medical Sales Value by Application (%), 2025 vs 2032
 Figure 57. India Polylactic Acid for Medical Sales Value (US$ Million), 2021–2032
 Figure 58. India Polylactic Acid for Medical Sales Value by Type (%), 2025 vs 2032
 Figure 59. India Polylactic Acid for Medical Sales Value by Application (%), 2025 vs 2032
 Figure 60. Polylactic Acid for Medical Industrial Chain
 Figure 61. Polylactic Acid for Medical Manufacturing Cost Structure
 Figure 62. Channels of Distribution (Direct Sales, and Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$3950

Single User License
Electronic

$5925

Multi User License
Electronic

$7900

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India